Loading...
Learn about our commitment to accurate, evidence-based peptide education and the standards that guide our content.
Peptide Authority exists to provide comprehensive, research-backed peptide education for the UK and EU audience. We aim to bridge the gap between complex scientific research and accessible public understanding, enabling informed decision-making while always emphasising the importance of professional medical guidance.
All information is derived from peer-reviewed research, clinical trials, and reputable medical literature. We prioritise human studies where available.
We present both potential benefits and known risks. We do not exaggerate claims or promise outcomes that are not supported by evidence.
Content is structured from plain English summaries for general readers to detailed mechanisms for researchers and practitioners.
Content is reviewed and updated regularly to reflect new research findings and regulatory changes.
Content is researched using primary scientific literature, with priority given to peer-reviewed journals and official regulatory sources.
All content is reviewed for scientific accuracy, balanced presentation, and appropriate caveats regarding research limitations.
Final review ensures content meets our editorial standards, includes appropriate disclaimers, and is accessible to our diverse audience.
Published content is monitored for accuracy and updated when new research or regulatory changes require revision.
Peptide Authority may receive compensation when visitors purchase products through our partner links, including Peptide Barn. This does not influence our editorial content, which is created independently based on research evidence. Our primary commitment is to educational accuracy and user safety.